Schulpis Kleopatra H, Tjamouranis Joanna, Karikas George A, Michelakakis Helen, Tsakiris Stylianos
Institute of Child Health, "Aghia Sophia" Children's Hospital, Athens, Greece.
Clin Biochem. 2002 Jun;35(4):281-5. doi: 10.1016/s0009-9120(02)00311-9.
To evaluate the activities of Na+,K+-ATPase and Mg2+-ATPase in erythrocyte membranes from phenylketonuric (PKU) patients and to correlate the enzyme activities with their blood phenylalanine (Phe) levels, biogenic amines as well as with their precursors tyrosine (Tyr) and tryptophan (Try).
Twenty three PKU patients were divided into group A (n = 12) on a restricted diet (Phe 1.57 +/- 0.52 mg/dL or 0.10 +/- 0.03 mM) and group B (n = 11) on a "loose" diet (Phe 24.45 +/- 1.50 mg/dL or 1.72 +/- 0.09 mM). The enzyme activities were measured spectrophotometrically, the amino acids with an automatic amino analyser and the biogenic amines with HPLC methods.
In group B, plasma amino acids (Tyr, Try), their biogenic amines [adrenaline (A), noradrenaline (NA), dopamine (DA) and serotonin (5HT)], (Na+,K+)-ATPase and Mg2+-ATPase activities were found remarkably decreased (p < 0.001).
High Phe and/or low NA, DA, 5HT plasma levels may indirectly inhibit the erythrocyte membrane Na+,K+-ATPase and Mg2+-ATPase in PKU patients. The observed enzyme inhibitions could be a very informative peripheral marker as regards the neurotoxic Phe brain effects.
评估苯丙酮尿症(PKU)患者红细胞膜中Na +,K + -ATP酶和Mg2 + -ATP酶的活性,并将酶活性与其血苯丙氨酸(Phe)水平、生物胺及其前体酪氨酸(Tyr)和色氨酸(Try)相关联。
23例PKU患者被分为A组(n = 12),采用严格饮食(Phe 1.57±0.52mg/dL或0.10±0.03mM),B组(n = 11)采用“宽松”饮食(Phe 24.45±1.50mg/dL或1.72±0.09mM)。用分光光度法测量酶活性,用自动氨基酸分析仪测量氨基酸,用HPLC方法测量生物胺。
在B组中,血浆氨基酸(Tyr,Try)、其生物胺[肾上腺素(A)、去甲肾上腺素(NA)、多巴胺(DA)和5-羟色胺(5HT)]、(Na +,K +)-ATP酶和Mg2 + -ATP酶活性显著降低(p <0.001)。
高Phe和/或低NA、DA、5HT血浆水平可能间接抑制PKU患者红细胞膜Na +,K + -ATP酶和Mg2 + -ATP酶。观察到的酶抑制作用可能是关于神经毒性Phe脑效应的一个非常有用的外周标志物。